op-724
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 29, 2019 (NCT04047160)
Timeline
Indications
Mechanism of action
- CREB-binding proteinINHIBITOR
CREBBP inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06144086 | Phase 2 | Dec 5, 2023 | Japan Agency for Medical Research and Development, Tokyo Metropolitan Komagome Hospital |
| NCT04688034 | Phase 1 | Jan 15, 2021 | Japan Agency for Medical Research and Development, OHARA Pharmaceutical Co., Ltd., Tokyo Metropolitan Komagome Hospital |
| NCT04047160 | Phase 1 | Aug 29, 2019 | Japan Agency for Medical Research and Development, OHARA Pharmaceutical Co., Ltd., Tokyo Metropolitan Komagome Hospital |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Japan Agency for Medical Research and Development | Government | 3 | 0 | 2 | 2019 |
| Tokyo Metropolitan Komagome Hospital | Academic/Hospital | 3 | 3 | 2 | 2019 |
| OHARA Pharmaceutical Co., Ltd. | For profit | 2 | 0 | 1 | 2019 |
3 organizations
Page 1 / 1